BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chigoho DM, Bridoux J, Hernot S. Reducing the renal retention of low- to moderate-molecular-weight radiopharmaceuticals. Curr Opin Chem Biol 2021;63:219-28. [PMID: 34325089 DOI: 10.1016/j.cbpa.2021.06.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Carrasco RA, Salih AK, Garcia MD, Khozeimeh ES, Adams GP, Phenix CP, Price EW. Development and Biodistribution of a Nerve Growth Factor Radioactive Conjugate for PET Imaging. Mol Imaging Biol 2023. [PMID: 36692661 DOI: 10.1007/s11307-023-01805-w] [Reference Citation Analysis]
2 Brandt F, Ullrich M, Wodtke J, Kopka K, Bachmann M, Löser R, Pietzsch J, Pietzsch HJ, Wodtke R. Enzymological Characterization of (64)Cu-Labeled Neprilysin Substrates and Their Application for Modulating the Renal Clearance of Targeted Radiopharmaceuticals. J Med Chem 2023;66:516-37. [PMID: 36595224 DOI: 10.1021/acs.jmedchem.2c01472] [Reference Citation Analysis]
3 Costa B, Corrêa LB, Silva PME, Jannini de Sá YAP, Guimarães FV, Alencar LMR, Simões RL, Helal-neto E, Ricci-junior E, Muller de Oliveira Henriques MDG, Rosas EC, Santos-oliveira R. Using pure Fucoidan and radiolabeled Fucoidan (99mTc-Fucoidan) as a new agent for inflammation diagnosis and therapy. Food Hydrocolloids for Health 2022;2:100049. [DOI: 10.1016/j.fhfh.2021.100049] [Reference Citation Analysis]
4 Kaihani S, Sadeghzadeh N, Abediankenari S, Abedi SM. [(99m)Tc]-labeling and evaluation of a new linear peptide for imaging of glioblastoma as a α(v)β(3)-positive tumor. Ann Nucl Med 2022;36:976-85. [PMID: 36097232 DOI: 10.1007/s12149-022-01786-w] [Reference Citation Analysis]
5 Koustoulidou S, Handula M, de Ridder C, Stuurman D, Beekman S, de Jong M, Nonnekens J, Seimbille Y. Synthesis and Evaluation of Two Long-Acting SSTR2 Antagonists for Radionuclide Therapy of Neuroendocrine Tumors. Pharmaceuticals (Basel) 2022;15:1155. [PMID: 36145375 DOI: 10.3390/ph15091155] [Reference Citation Analysis]
6 Valpreda G, Trachsel B, Vogel V, Schibli R, Mu L, Behe M. Dual MVK cleavable linkers effectively reduce renal retention of 111In-fibronectin-binding peptides. Bioorganic & Medicinal Chemistry 2022. [DOI: 10.1016/j.bmc.2022.117040] [Reference Citation Analysis]
7 Lau J, Lee H, Rousseau J, Bénard F, Lin K. Application of Cleavable Linkers to Improve Therapeutic Index of Radioligand Therapies. Molecules 2022;27:4959. [DOI: 10.3390/molecules27154959] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Feng Y, Meshaw R, McDougald D, Zhou Z, Zhao XG, Jannetti SA, Reiman RE, Pippen E, Marjoram R, Schaal JL, Vaidyanathan G, Zalutsky MR. Evaluation of an 131I-labeled HER2-specific single domain antibody fragment for the radiopharmaceutical therapy of HER2-expressing cancers. Sci Rep 2022;12:3020. [PMID: 35194100 DOI: 10.1038/s41598-022-07006-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]